Capecitabine Maintenance in Metastatic Nasopharyngeal Carcinoma

被引:0
|
作者
Ganguly, Shuvadeep [1 ]
Gogia, Ajay [1 ]
机构
[1] All India Inst Med Sci, Dr BRA Inst Rotary Canc Hosp, Dept Med Oncol, New Delhi, India
关键词
D O I
10.1001/jamaoncol.2022.2062
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1223 / 1224
页数:2
相关论文
共 50 条
  • [1] Capecitabine monotherapy for recurrent and metastatic nasopharyngeal carcinoma
    Mehdi, A.
    Hela, R.
    ORAL ONCOLOGY, 2009, : 191 - 191
  • [2] Maintenance Capecitabine in Recurrent or Metastatic Nasopharyngeal Carcinoma-Magic Bullet or Pandora's Box?
    Ng, Wai-Tong
    Chua, Melvin L. K.
    Lee, Anne W. M.
    JAMA ONCOLOGY, 2022, 8 (04) : 524 - 525
  • [3] The role of capecitabine as maintenance therapy in de novo metastatic nasopharyngeal carcinoma: A propensity score matching study
    Sun, Xue-Song
    Liu, Sai-Lan
    Liang, Yu-Jing
    Chen, Qiu-Yan
    Li, Xiao-Yun
    Tang, Lin-Quan
    Mai, Hai-Qiang
    CANCER COMMUNICATIONS, 2020, 40 (01) : 32 - 42
  • [4] Maintenance Capecitabine in Recurrent or Metastatic Nasopharyngeal Carcinoma-Magic Bullet or Pandora's Box? Reply
    Hope, Thomas A.
    Calais, Jeremie
    JAMA ONCOLOGY, 2022, 8 (04) : 644 - 645
  • [5] Maintenance metronomic chemotherapy for metastatic/recurrent nasopharyngeal carcinoma
    Twu, Chih-Wen
    Lin, Po-Ju
    Tsou, Hsiao-Hui
    Liu, Yi-Chun
    Jiang, Rong-San
    Liang, Kai-Li
    Lin, Tian-Yun
    Wang, Wen-Yi
    Lin, Jin-Ching
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2022, 44 (06): : 1453 - 1461
  • [6] Maintenance metronomic chemotherapy for recurrent/metastatic nasopharyngeal carcinoma
    Wu, C.
    Wang, W. Y.
    Twu, C. W.
    Lin, P. J.
    Liu, Y. C.
    Lin, J. C.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S515 - S515
  • [7] Capecitabine monotherapy for recurrent and metastatic nasopharyngeal cancer
    Chua, Daniel
    Wei, William I.
    Sham, Jonathan S. T.
    Au, Gordon K. H.
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2008, 38 (04) : 244 - 249
  • [8] Capecitabine therapy in recurrent/metastatic nasopharyngeal cancers.
    Alshamsan, Bader, I
    Alata, Maaz Kamal
    Gad, Ahmed
    Alzahrani, Mashari J.
    Elhassan, Tusneem
    Atallah, Jean Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [9] Capecitabine maintenance therapy after induction chemotherapy in newly diagnosed metastatic nasopharyngeal carcinoma: An open-label, randomized, controlled, phase trial.
    Liu, Guo-Ying
    Li, Wang-Zhong
    Wang, De-Shen
    Liang, Hu
    Lv, Xing
    Ye, Yan-Fang
    Zhao, Chong
    Ke, Liang-Ru
    Qiang, Mengyun
    Cao, Xun
    Lv, Shu-Hui
    Lu, Nian
    Bei, Wei-Xin
    Cai, Zhuocheng
    Chen, Xi
    Xie, Jun-Zhi
    Liang, Chixiong
    Guo, Xiang
    Xia, Weixiong
    Xiang Yanqun
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [10] Oral Maintenance Chemotherapy Using S-1/Capecitabine in Metastatic Nasopharyngeal Carcinoma Patients After Systemic Chemotherapy: A Single-Institution Experience
    Guo, Qiaojuan
    Chen, Mengwei
    Xu, Hanchuan
    Lu, Tianzhu
    Zhou, Han
    Chen, Yanyan
    Zong, Jingfeng
    Xu, Yun
    Chen, Bijuan
    Wang, Bingyi
    Zhu, Lili
    Pan, Jianji
    Lin, Shaojun
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 1387 - 1396